Latest filing published 15 Sept 2025 for Camp4 Therapeutics Corp, €3.8M. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
5AM Partners VI, LLC is a declared insider at 4 companies; the most frequent names are CinCor Pharma, Inc., Camp4 Therapeutics Corp and Enliven Therapeutics, Inc. Between 11 January 2022 and 11 September 2025, the trades on record add up to 14 filings.
In open-market terms, that means 3 purchases worth €16.3M on one side and 4 sales worth €23.1M on the other. Taken together, the sales exceed the purchases by €6.8M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2025 alone, the filings show 1 purchase and no sales.
A typical purchase (the median) is worth €3.8M. 2 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The latest filing, published on 15 September 2025, reports an open-market purchase of €3.8M in Camp4 Therapeutics Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations